The hepatitis C virus, or HCV, causes a chronic liver infection that can lead to permanent liver scarring and, in dire cases, cancer. It affects around 71 million people worldwide and causes ...
A new discovery points the way toward an effective HCV vaccine. A team led by scientists at Scripps Research and the University of Amsterdam has achieved an important goal in virology: mapping, at ...
Around 300,000 people die from hepatitis C every year. A new study has mapped the protein complex that enables the virus to infect our cells, potentially paving the way for an effective vaccine.
The nonstructural 5B (NS5B) protein is the catalytic core of the hepatitis C virus replication machinery. The RNA-dependent RNA polymerase activity of NS5B supports a staggering rate of viral ...
In a recent study published in Scientific Reports, researchers identified serological Hepatitis C virus (HCV) signatures and human immunodeficiency virus (HIV) signatures through the secondary ...
Individuals living with both HIV and hepatitis C virus (HCV) who ultimately developed hepatocellular carcinoma (HCC) showed greater suppression of plasma extracellular vesicles (pEVs) after HCV ...
The hepatitis C virus, or HCV, causes a chronic liver infection that can lead to permanent liver scarring and, in dire cases, cancer. It affects around 71 million people worldwide and causes ...
Lisa Eshun-Wilson receives funding from the National Science Foundation. Alba Torrents de la Peña receives funding from Netherlands Organization for Scientific Research (NWO) Rubicon Grant 45219118.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback